Goldman Weighs In On Tesla Robotaxi Launch
Tesla officially launched its long-anticipated self-driving Robotaxi service in Austin, Texas, on Sunday. A select group of early-access users—many of them FSD beta testers and Tesla influencers on X—have begun sharing their experiences as the AI car company sets its sights on competing near-term with Waymo and, more broadly, becoming a leader in the autonomous ride-hailing industry by 2030.
A team of Goldman analysts, led by Mark Delaney, provided their initial assessment of the robotaxi service in Austin, which features a fleet of self-driving Model Ys.
They discuss three key items from the launch, including:
-
Our initial thoughts on performance of the early rides, which generally show a good degree of drive smoothness in our opinion but with one user posting a navigation issue with improper use of a left turn lane and the vehicle driving temporarily in the turn lane for traffic going the other direction;
-
How Tesla’s Austin service currently compares to Waymo, including the operating area;
-
Our views on how fast Tesla will scale (we continue to expect it to be measured in the near-term).
Delaney said the initial feedback posted on X about Robotaxi has mainly been positive, with users praising the smooth ride experience and tech integration, including personalized music preferences and an in-car customer support feature. However, one early ride encountered a notable navigation error.
This video is circulating on X trying to paint Tesla in a bad light.
It clearly shows the Robotaxi attempting a turn, detecting an error and correcting itself.
This is exactly how a human driver would react and honestly, it reassures me that it’s catching errors and not getting… pic.twitter.com/aamPzfxqke
— Lior (@liorsela) June 23, 2025
“We consider this navigation error as somewhat concerning about the overall level of tech readiness, especially in light of the limited number of vehicles on the road, but also we appreciate that this behavior is not unprecedented to see from human drivers either,” the analysts noted.
Tesla had previously indicated that its pilot fleet would consist of 10–20 vehicles, and the service is currently restricted to a limited geographic area in Austin and available only from 6 a.m. to midnight local time. A Tesla employee remains seated in each vehicle, suggesting the company still requires human supervision.
In contrast, Alphabet’s Waymo operates across 37 square miles of Austin on a 24/7 basis, accessible to all Uber users. Tesla is charging a flat fee of $4.20 per ride, while Waymo’s pricing is dynamic, based on Uber’s existing fare model.
On the subject of Robotaxi scaling in Austin, the analysts said:
The use of an Austin-specific tech stack, a Tesla employee being present in the vehicle (albeit on the passenger side), and the navigation/lane issue reported in the first day of use suggests scaling will be slow in the near-term in our view — As we discussed in our note from 6/20, we hadn’t initially expected a Tesla employee to be in vehicle. Given this news, the navigation related error from one early consumer ride, and other factors like geofencing and a version of the software that at least for now is specific to Austin, suggests in our view that scaling in the near-term will be slow. We also believe this suggests that it will be some time before consumers can use FSD on their personal vehicles in a wide operating area.
Adding:
Separately, the regulatory environment will be key to monitor and could determine the speed of the ramp as well. California currently requires permits for robotaxi deployments, and on 6/20 the Texas governor signed a bill that requires robotaxi/AV operator permits starting in September. However, new federal rules could help speed AV adoption.
Delaney pointed out that Tesla added more than $90 billion in market capitalization leading up to the Robotaxi launch, nearly “double Waymo’s reported valuation of >$45 bn as of October 2024.” In other words, much of the Robotaxi optimism has been priced in.
The analysts maintained a “Neutral” rating with a 12-month price target of $285, or about 20% below Monday’s closing price. Their valuation model suggests Robotaxi could add anywhere from $2.50 to over $80 per share in value by 2040, depending on the eventual fleet size and profit margins.
Earlier this month, a separate Goldman note outlined that the autonomous vehicles era is just beginning and about to enter hyperscaling in North America.
Tyler Durden Tue, 06/24/2025 – 14:25
Source: https://freedombunker.com/2025/06/24/goldman-weighs-in-on-tesla-robotaxi-launch/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
